| Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial) SM Grundy, GL Vega, Z Yuan, WP Battisti, WE Brady, J Palmisano The American journal of cardiology 95 (4), 462-468, 2005 | 440 | 2005 |
| Serum antioxidants and age-related macular degeneration in a population-based case-control study JA Mares-Perlman, WE Brady, R Klein, BEK Klein, P Bowen, ... Archives of ophthalmology 113 (12), 1518-1523, 1995 | 435 | 1995 |
| Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study J Farley, WE Brady, V Vathipadiekal, HA Lankes, R Coleman, MA Morgan, ... The lancet oncology 14 (2), 134-140, 2013 | 414 | 2013 |
| Dietary fat and age-related maculopathy JA Mares-Perlman, WE Brady, R Klein, GM VandenLangenberg, ... Archives of Ophthalmology 113 (6), 743-748, 1995 | 412 | 1995 |
| A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on … TA Pearson, MA Denke, PE McBride, WP Battisti, WE Brady, J Palmisano Mayo Clinic Proceedings 80 (5), 587-595, 2005 | 380 | 2005 |
| Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study GM VandenLangenberg, JA Mares-Perlman, R Klein, BEK Klein, ... American journal of epidemiology 148 (2), 204-214, 1998 | 337 | 1998 |
| Human serum carotenoid concentrations are related to physiologic and lifestyle factors WE Brady, JA Mares-Perlman, P Bowen, M Stacewicz-Sapuntzakis The Journal of nutrition 126 (1), 129-137, 1996 | 331 | 1996 |
| Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia CM Ballantyne, MA Blazing, TR King, WE Brady, J Palmisano The American journal of cardiology 93 (12), 1487-1494, 2004 | 301 | 2004 |
| Association of zinc and antioxidant nutrients with age-related maculopathy JA Mares-Perlman, R Klein, BEK Klein, JL Greger, WE Brady, M Palta, ... Archives of ophthalmology 114 (8), 991-997, 1996 | 279 | 1996 |
| Diet and nuclear lens opacities JA Mares-Perlman, WE Brady, BEK Klein, R Klein, GJ Haus, M Palta, ... American journal of epidemiology 141 (4), 322-334, 1995 | 215 | 1995 |
| Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study EA Alvarez, WE Brady, JL Walker, J Rotmensch, XC Zhou, JE Kendrick, ... Gynecologic oncology 129 (1), 22-27, 2013 | 185 | 2013 |
| Vitamin supplement use and incident cataracts in a population-based study JA Mares-Perlman, BJ Lyle, R Klein, AI Fisher, WE Brady, ... Archives of Ophthalmology 118 (11), 1556-1563, 2000 | 157 | 2000 |
| Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients AL Catapano, MH Davidson, CM Ballantyne, WE Brady, RA Gazzara, ... Current medical research and opinion 22 (10), 2041-2053, 2006 | 151 | 2006 |
| A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary … RL Coleman, WE Brady, DS McMeekin, PG Rose, JT Soper, SS Lentz, ... Gynecologic oncology 122 (1), 111-115, 2011 | 132 | 2011 |
| Serum carotenoids and tocopherols and severity of nuclear and cortical opacities. JA Mares-Perlman, WE Brady, BE Klein, R Klein, M Palta, P Bowen, ... Investigative ophthalmology & visual science 36 (2), 276-288, 1995 | 121 | 1995 |
| Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the M alignant G erm C ell T umor I nternational C ollaborative F Pashankar, JP Hale, H Dang, M Krailo, WE Brady, ... Cancer 122 (2), 230-237, 2016 | 118 | 2016 |
| Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial DM Gershenson, A Miller, WE Brady, J Paul, K Carty, W Rodgers, D Millan, ... The Lancet 399 (10324), 541-553, 2022 | 108 | 2022 |
| Defining total corporate health and safety costs significance and impact: review and recommendations W Brady, J Bass, R Moser Jr, GW Anstadt, RR Loeppke, R Leopold Journal of Occupational and Environmental Medicine 39 (3), 224-231, 1997 | 99 | 1997 |
| Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group J Brown, WE Brady, J Schink, L Van Le, M Leitao, SD Yamada, ... Cancer 120 (3), 344-351, 2014 | 97 | 2014 |
| Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome M Denke, T Pearson, P McBride, RA Gazzara, WE Brady, ... Diabetes and Vascular Disease Research 3 (2), 93-102, 2006 | 90 | 2006 |
Catapano A or Catapano ALUniversity of Milan and Multimedica IRCCSVerified email at unimi.it
